Acrivastine
{{drugbox |
| IUPAC_name = (E)-3-{6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-yl-
prop-1-enyl]pyridin-2-yl}prop-2-enoic acid
| image =
| CAS_number = 87848-99-5
| ATC_prefix = R06
| ATC_suffix = AX18
| PubChem = 5284514
| DrugBank =
| C = 22 | H = 24 | N = 2 | O = 2
| molecular_weight = 348.438 g/mol
| smiles = CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = 1.5 hours
| excretion = Renal
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category=
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
}}
WikiDoc Resources for Acrivastine |
Articles |
---|
Most recent articles on Acrivastine Most cited articles on Acrivastine |
Media |
Powerpoint slides on Acrivastine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Acrivastine at Clinical Trials.gov Clinical Trials on Acrivastine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Acrivastine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Acrivastine Discussion groups on Acrivastine Patient Handouts on Acrivastine Directions to Hospitals Treating Acrivastine Risk calculators and risk factors for Acrivastine
|
Healthcare Provider Resources |
Causes & Risk Factors for Acrivastine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors.
It is sold under the brand name Benadryl Allergy Relief in the U.K. by Pfizer, not to be confused with Benadryl Once a Day, which is cetirizine and is also sold by Pfizer in the U.K. This drug is currently not available as a generic in the U.K. [1]
In the U.S., acrivastine is the active ingrediant in the Semprex brand. Semprex-D is also acrivastine based, but also contains a decongestant.
References
- ↑ Cheapest hayfever remedies 2007, Money Saving expert, May 15th,2007